QQ客服 官方微博 反馈留言

	Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.
	Xing Qin; Haiyan Guo; Xiaoning Wang; Xueqin Zhu; Ming Yan; Xu Wang; Qin Xu; Jianbo Shi; Eryi Lu; Wantao Chen
刊名	Genome biology
	2019
卷号	Vol.20 No.1页码:12
关键词	CDKN1B Cancer-associated fibroblasts Cisplatin resistance Exosome Head and neck cancer ING5 miR-196a
ISSN号	1474-760X
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4602367
专题	湖南大学
作者单位	1.Department of Oral and Maxillofacial-Head & 2.Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, People's Republic of China. Department of Clinical Laboratory, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201999, People's Republic of China. Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, National Clinical Research Center of Stomatology, Shanghai, 200011, People's Republic of China. Department of Stomatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Road, Shanghai, 200127, People's Republic of China. lueryi222@12 3.com. Department of Oral and Maxillofacial-Head & 4.Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, People's Republic of China. chenwantao196323@sjtu.edu.cn. Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, National Clinical Research Center of Stomatology, Shanghai, 200011, People's Republic of China. chenwantao196323@sjtu.edu.cn. Department of Oral and Maxillofacial-Head & 5.Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, People's Republic of China. zjjshuobo@16 6.com.
推荐引用方式 GB/T 7714	Xing Qin,Haiyan Guo,Xiaoning Wang,et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.[J]. Genome biology,2019,Vol.20 No.1:12.
APA	Xing Qin.,Haiyan Guo.,Xiaoning Wang.,Xueqin Zhu.,Ming Yan.,...&Jianjun Zhang.(2019).Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5..Genome biology,Vol.20 No.1,12.
MLA	Xing Qin,et al."Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.".Genome biology Vol.20 No.1(2019):12.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。